1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Biomarcadores y Abordaje Personalizado del Cáncer (BioPAC)

Biomarcadores y Abordaje Personalizado del Cáncer (BioPAC)

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Alcalá S, Sainz B.

    The dark side of radiotherapy-induced cell death in cancer.

    EBioMedicine . 40: 7-8. Nº de citas: 2

    [doi:10.1016/j.ebiom.2019.01.047]

  • Hermann PC, Sainz B.

    Pancreatic cancer stem cells: A state or an entity?

    Seminars in cancer biology . 53: 223-231. Nº de citas: 43

    [doi:10.1016/j.semcancer.2018.08.007]

  • Friederich MW, Timal S, Powell CA, Dallabona C, Kurolap A, Palacios-Zambrano S, Bratkovic D, Derks TGJ, Bick D, Bouman K, Chatfield KC, Damouny-Naoum N, Dishop MK, Falik-Zaccai TC, Fares F, Fedida A, Ferrero I, Gallagher RC, Garesse R, Gilberti M, González C, Gowan K, Habib C, Halligan RK, Kalfon L, Knight K, Lefeber D, Mamblona L, Mandel H, Mory A, Ottoson J, Paperna T, Pruijn GJM, Rebelo-Guiomar PF, Saada A, Sainz B, Salvemini H, Schoots MH, Smeitink JA, Szukszto MJ, Ter Horst HJ, van den Brandt F, van Spronsen FJ, Veltman JA, Wartchow E, Wintjes LT, Zohar Y, Fernández-Moreno MA, Baris HN, Donnini C, Minczuk M, Rodenburg RJ, Van Hove JLK.

    Pathogenic variants in glutamyl-tRNA Gln amidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder.

    NATURE COMMUNICATIONS . 9(1): 4065-4065. Nº de citas: 20

    [doi:10.1038/s41467-018-06250-w]

  • Zagorac, Sladjana, Garcia-Bermejo, Laura, Sainz, Bruno, Jr..

    The Epigenetic Landscape of Pancreatic Cancer Stem Cells

    Epigenomes . 2(2): . Nº de citas: 5

    [doi:10.3390/epigenomes2020010]

  • Alguacil-Núñez C, Ferrer-Ortiz I, García-Verdú E, López-Pirez P, Llorente-Cortijo IM, Sainz B.

    Current perspectives on the crosstalk between lung cancer stem cells and cancer-associated fibroblasts.

    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY . 125: 102-110. Nº de citas: 17

    [doi:10.1016/j.critrevonc.2018.02.015]

  • González I, Earl J, Fernández LJ, Sainz B, Pinto A, Monge R, Alcalá S, Castillejo A, Soto JL, Carrato A.

    A Label Free Disposable Device for Rapid Isolation of Rare Tumor Cells from Blood by Ultrasounds.

    MICROMACHINES . 9(3): . Nº de citas: 13

    [doi:10.3390/mi9030129]

  • Djurec M, Graña O, Lee A, Troulé K, Espinet E, Cabras L, Navas C, Blasco MT, Martín-Díaz L, Burdiel M, Li J, Liu Z, Vallespinós M, Sanchez-Bueno F, Sprick MR, Trumpp A, Sainz B, Al-Shahrour F, Rabadan R, Guerra C, Barbacid M.

    Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors.

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA . 115(6): 1147-1156. Nº de citas: 79

    [doi:10.1073/pnas.1717802115]

  • Valle S, Martin-Hijano L, Alcalá S, Alonso-Nocelo M, Sainz B.

    The Ever-Evolving Concept of the Cancer Stem Cell in Pancreatic Cancer.

    Cancers . 10(2): . Nº de citas: 65

    [doi:10.3390/cancers10020033]

  • D'Errico G, Machado HL, Sainz B.

    A current perspective on cancer immune therapy: step-by-step approach to constructing the magic bullet.

    Clinical And Translational Medicine . 6(1): 3-3. Nº de citas: 44

    [doi:10.1186/s40169-016-0130-5]

  • da Silva IL, Montero-Montero L, Martín-Villar E, Martin-Pérez J, Sainz B, Renart J, Toscano Simões R, Soares Veloso É, Salviano Teixeira C, de Oliveira MC, Ferreira E, Quintanilla M.

    Reduced expression of the murine HLA-G homolog Qa-2 is associated with malignancy, epithelial-mesenchymal transition and stemness in breast cancer cells.

    SCIENTIFIC REPORTS . 7(1): 6276-6276. Nº de citas: 8

    [doi:10.1038/s41598-017-06528-x]

  • López-Gómez M, Casado E, Muñoz M, Alcalá S, Moreno-Rubio J, D'Errico G, Jiménez-Gordo AM, Salinas S, Sainz B.

    Current evidence for cancer stem cells in gastrointestinal tumors and future research perspectives.

    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY . 107: 54-71. Nº de citas: 3

    [doi:10.1016/j.critrevonc.2016.08.006]

  • Zagorac S, Alcala S, Fernandez Bayon G, Bou Kheir T, Schoenhals M, González-Neira A, Fernandez Fraga M, Aicher A, Heeschen C, Sainz B.

    DNMT1 Inhibition Reprograms Pancreatic Cancer Stem Cells via Upregulation of the miR-17-92 Cluster

    CANCER RESEARCH . 76(15): 4546-4558. Nº de citas: 71

    [doi:10.1158/0008-5472.CAN-15-3268]

  • Sancho P, Alcala S, Usachov V, Hermann PC, Sainz B.

    The ever-changing landscape of pancreatic cancer stem cells.

    Pancreatology . 16(4): 489-496. Nº de citas: 19

    [doi:10.1016/j.pan.2016.04.004]

  • Sainz B, Carron E, Vallespinós M, Machado HL.

    Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic Strategies

    MEDIATORS OF INFLAMMATION . 2016: 9012369-9012369. Nº de citas: 66

    [doi:10.1155/2016/9012369]

  • Cioffi M, Vallespinos-Serrano M, Trabulo SM, Fernandez-Marcos PJ, Firment AN, Vazquez BN, Vieira CR, Mulero F, Camara JA, Cronin UP, Perez M, Soriano J, G Galvez B, Castells-Garcia A, Haage V, Raj D, Megias D, Hahn S, Serrano L, Moon A, Aicher A, Heeschen C.

    MiR-93 Controls Adiposity via Inhibition of Sirt7 and Tbx3

    CELL REPORTS . 12(10): 1594-1605. Nº de citas: 79

    [doi:10.1016/j.celrep.2015.08.006]

  • Rivera F, Longo F, Martín Richard M, Richart P, Alsina M, Carmona A, Custodio AB, Fernández Montes A, Gallego J, Fleitas Kanonnikoff T.

    SEOM-GEMCAD-TTD clinical guideline for the diagnosis and treatment of gastric cancer (2023).

    CLINICAL & TRANSLATIONAL ONCOLOGY . : .

    [doi:10.1007/s12094-024-03600-7]

  • Guerrero P, Albarrán V, González-Merino C, García de Quevedo C, Sotoca P, Chamorro J, Rosero DI, Barrill A, Alía V, Calvo JC, Moreno J, Pérez de Aguado P, Álvarez-Ballesteros P, San Román M, Serrano JJ, Soria A, Olmedo ME, Saavedra C, Cortés A, Gómez A, Lage Y, Ruiz Á, Ferreiro MR, Longo F, Guerra E, Martínez-Delfrade Í, Garrido P, Gajate P.

    Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients.

    ONCOLOGIST . : .

    [doi:10.1093/oncolo/oyae284]

  • Cerezuela-Fuentes P, Gonzalez-Cao M, Puertolas T, Manzano JL, Maldonado C, Yelamos O, Berciano-Guerrero MA, Martin-Liberal J, Muñoz-Couselo E, Espinosa E, Drozdowskyj A, Berrocal A, Soria A, Marquez-Rodas I, Martin-Algarra S, Quindos M, Puig S.

    Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis.

    CLINICAL & TRANSLATIONAL ONCOLOGY . : .

    [doi:10.1007/s12094-024-03583-5]